Zhou M - Search Results

1

Differential expression of caveolin-1 in renal neoplasms.

Tamaskar I, Choueiri TK, Sercia L, Rini B, Bukowski R, Zhou M. Tamaskar I, et al. Among authors: zhou m. Cancer. 2007 Aug 15;110(4):776-82. doi: 10.1002/cncr.22838. Cancer. 2007. PMID: 17594718 Free article.

2

Expression of EphA2 is prognostic of disease-free interval and overall survival in surgically treated patients with renal cell carcinoma.

Herrem CJ, Tatsumi T, Olson KS, Shirai K, Finke JH, Bukowski RM, Zhou M, Richmond AL, Derweesh I, Kinch MS, Storkus WJ. Herrem CJ, et al. Among authors: zhou m. Clin Cancer Res. 2005 Jan 1;11(1):226-31. Clin Cancer Res. 2005. PMID: 15671550

3

The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms.

Zhou M, Roma A, Magi-Galluzzi C. Zhou M, et al. Clin Lab Med. 2005 Jun;25(2):247-57. doi: 10.1016/j.cll.2005.01.004. Clin Lab Med. 2005. PMID: 15848735 Review.

4

Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma.

Gemmill RM, Zhou M, Costa L, Korch C, Bukowski RM, Drabkin HA. Gemmill RM, et al. Among authors: zhou m. Br J Cancer. 2005 Jun 20;92(12):2266-77. doi: 10.1038/sj.bjc.6602646. Br J Cancer. 2005. PMID: 15956968 Free PMC article.

5

Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma.

Choueiri TK, Rini B, Garcia JA, Baz RC, Abou-Jawde RM, Thakkar SG, Elson P, Mekhail TM, Zhou M, Bukowski RM. Choueiri TK, et al. Among authors: zhou m. Ann Oncol. 2007 Feb;18(2):249-55. doi: 10.1093/annonc/mdl371. Epub 2006 Oct 23. Ann Oncol. 2007. PMID: 17060490 Free article.

6

Phase II trial of capecitabine and rHu-interferon-alpha-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity.

Segota E, Mekhail T, Olencki T, Hutson TE, Dreicer R, Wacker B, Osterwalder B, Elson P, Zhou M, Bukowski RM. Segota E, et al. Among authors: zhou m. Urol Oncol. 2007 Jan-Feb;25(1):46-52. doi: 10.1016/j.urolonc.2006.02.016. Urol Oncol. 2007. PMID: 17208138 Clinical Trial.

7

Differential expression of melanocytic markers in myoid, lipomatous, and vascular components of renal angiomyolipomas.

Roma AA, Magi-Galluzzi C, Zhou M. Roma AA, et al. Among authors: zhou m. Arch Pathol Lab Med. 2007 Jan;131(1):122-5. doi: 10.5858/2007-131-122-DEOMMI. Arch Pathol Lab Med. 2007. PMID: 17227112 Free article.

8

The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell carcinoma: a call for standardized methods for immunohistochemical evaluation.

Cohen D, Lane B, Jin T, Magi-Galluzzi C, Finke J, Rini BI, Bukowski RM, Zhou M. Cohen D, et al. Among authors: zhou m. Clin Genitourin Cancer. 2007 Mar;5(4):264-70. doi: 10.3816/CGC.2007.n.002. Clin Genitourin Cancer. 2007. PMID: 17553206

9

Neoadjuvant docetaxel treatment for locally advanced prostate cancer: a clinicopathologic study.

Magi-Galluzzi C, Zhou M, Reuther AM, Dreicer R, Klein EA. Magi-Galluzzi C, et al. Among authors: zhou m. Cancer. 2007 Sep 15;110(6):1248-54. doi: 10.1002/cncr.22897. Cancer. 2007. PMID: 17674353 Free article. Clinical Trial.

10

Renal neuroendocrine tumours: a clinicopathological study.

Lane BR, Chery F, Jour G, Sercia L, Magi-Galluzzi C, Novick AC, Zhou M. Lane BR, et al. Among authors: zhou m. BJU Int. 2007 Nov;100(5):1030-5. doi: 10.1111/j.1464-410X.2007.07116.x. Epub 2007 Sep 3. BJU Int. 2007. PMID: 17784891

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,770 results

Search Page

Filters